Fluorecare 4-in-1 Combo Antigen Test Kit

The Fluorecare 4-in-1 Combo Antigen Test Kit is a diagnostic device designed for the simultaneous detection of four respiratory viruses: SARS-CoV-2, Influenza A, Influenza B, and Respiratory Syncytial Virus (RSV). This test is intended for home use, allowing individuals to perform self-testing with nasal swab samples. Results are typically available within 15 minutes, providing rapid identification of these infections. The test has been validated for use with various SARS-CoV-2 variants, including Alpha, Beta, Gamma, Delta, and Omicron. It is CE marked, indicating compliance with European Union health, safety, and environmental protection standards. The Fluorecare brand is associated with Shenzhen Microprofit Bio-tech Co., Ltd., a company based in China. The test kits are manufactured in multiple countries, including China, and are distributed in various regions, including Europe and the United States. In the U.S., NovaBay Pharmaceuticals has entered into an agreement to distribute the Fluorecare COVID-19 test kit, making it accessible to healthcare professionals and consumers. This collaboration aims to provide rapid and reliable diagnostic solutions for respiratory infections, enhancing the ability to manage and control the spread of these viruses effectively.